UNSPSC 51171981: Carbenoxolone

This classification denotes a hydroxysteroid dehydrogenase inhibitor with the molecular formula C34H50O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MM6384NG73, chemically known as olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, hydrogen succinate but generally known as carbenoxolone, which bears US NIH Compound Identifier 21913. Carbenoxolone comes in base, adrenochrome, and sodium forms. European Medicines Agency schedules Carbenoxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06123MIG.

UNSPSC 51171981 Carbenoxolone is a Commodity code that covers a specific pharmaceutical active ingredient; however, the recent state and local opportunities tagged under this code reflect a fundamental mismatch between the code's nominal scope and actual procurement activity. The three recent opportunities span offender drug testing services, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical distribution — none of which center on carbenoxolone as a procurement line item. The Collin County Community Supervision and Corrections Department RFP (2026-327) solicits specimen collection and drug testing services (immunoassay screening with confirmation, oral fluid and hair testing) rather than a specific active ingredient. The Texas HHS Commission RFI (HHS0017013) seeks vendor information about direct contracting between state pharmacy benefit programs and manufacturers, absent any carbenoxolone-specific demand signal. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP (S1070000015802) establishes contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, Morris & Dickson Co.), again without carbenoxolone as a named product line.

The issuing bodies include a Texas county criminal-justice supervision agency, a state health and human services commission, and a multi-state cooperative purchasing alliance. The geographic spread encompasses Texas (Collin County, Texas HHS Commission) and Minnesota (MMCAP, which includes Oregon as a participating jurisdiction). No evidence of recent state or local procurement activity specifically targeting carbenoxolone as a line item appears in the available opportunities; the code shows little relevant recent activity for this specific pharmaceutical ingredient in the state and local market.